Wellgistics Health Inc. has expanded its partnership with Tollo Health, LLC, enhancing its service offerings to include telehealth and mental health AI capabilities. Through Tollo Health's subsidiary, TolloCare, LLC, the collaboration will provide telemedicine services for patients using GLP-1 agonist drugs and those affected by Long COVID. TolloCare has enlisted a telemedicine provider with over 5,000 physicians to deliver medical consultations and prescriptions, and will also build a specialized Long COVID physician network. Additionally, Tollo Health has partnered with a San Francisco Bay Area startup to deploy a mental health AI app, aiming to improve patient outcomes with advanced digital tools. The expanded partnership will also support Wellgistics' collaboration with NFL Alumni Health.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wellgistics Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-006815), on February 13, 2026, and is solely responsible for the information contained therein.
Comments